Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 385

Hearst Ventures unveils fresh hires

Kunal Mehta has been promoted to principal at the media group's corporate venturing unit, which has also hired senior associate Jacqueline Cegla and associate Isabel Lo.

Jun 20, 2020

Credit Suisse drives $21m to MayStreet

The capital markets data provider has completed a series A round led by Credit Suisse Asset Management’s Next Investors unit.

Jun 19, 2020

Botkeeper accounts for $25m series B

The accounting software provider boosted its overall funding to more than $47m as Google subsidiary Gradient Ventures returned to reinvest.

Jun 19, 2020

Corporate venturing deal net: 15-19 June 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jun 19, 2020

Urbint turns to corporates for $20m

Salesforce and National Grid took part in a series B round for the infrastructure monitoring technology developer that was co-led by Petronas subsidiary Piva.

Jun 19, 2020

Corporates make Wise investment in $15m round

Gradient Ventures and Prologis Ventures both contributed to a round that will fund research and development for the logistics management platform developer.

Jun 19, 2020

Copado scopes $26m in series B round

Salesforce Ventures returned to participate in a round that hiked DevOps technology provider Copado's overall funding to $47m.

Jun 19, 2020

Palantir calls in $500m from Sompo Holdings

Big data analysis provider Palantir has followed a $50m investment by Fujitsu with $500m from its partner in a Japanese joint venture.

Jun 19, 2020

Forma forces its way to $278m IPO

The Novartis and Eli Lilly-backed cancer and haematologic disease drug developer will go public today having expanded the size of its offering.

Jun 19, 2020

Repare reaches public markets with $220m

The targeted oncology drug developer, which counts Bristol Myers Squibb and Celgene as investors, is floating above its range in an upsized offering.

Jun 19, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here